Next 10 |
2024-07-03 04:38:40 ET Summary AbbVie reported first quarter results and although results were not great, the company managed to set off declining Humira sales. Especially, Skyrizi and Rinvoq are expected to keep growing at a high pace and AbbVie made a few major acquisitions that...
2024-07-02 12:16:27 ET Summary Schwab US Dividend Equity ETF is criticized for weaker performance and disappointing 4% dividend increase in 2023. Despite short-term disappointments, ETF's long-term focus on dividend growth remains strong. Recent performance dip should not disc...
2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...
AbbVie to Host Second-Quarter 2024 Earnings Conference Call PR Newswire NORTH CHICAGO, Ill. , July 2, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its second-quarter 2024 financial results on Thursday, July 25, 2024 , before the market opens. AbbVie wi...
2024-07-01 10:48:00 ET It's been a big year for most stocks, with the S&P 500 index up about 24% over the past 12 months. A rising market is wonderful for the stocks already in your portfolio, but finding new investment opportunities is a lot more challenging than it was a year ago....
2024-07-01 08:23:23 ET More on AbbVie AbbVie: 5 Reasons That Make A Buy Case AbbVie: Turnaround Lurking After The Correction Pain (Upgrade) AbbVie, Genmab blood cancer therapy endorsed in EU AbbVie buys bowel disease drug developer Celsius for $250M ...
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer PR Newswire As Previously Announced, Richard A. Gonzalez Retires as Chief Executive Officer to Become Executive Chairman Robert A. Michael Joins AbbVie Board of Directors NORTH CHICAGO, Ill....
2024-07-01 06:50:00 ET Most retirees prefer low turnover in their investment portfolios. The less drama, the better. That way, they can focus on doing what they enjoy instead of worrying about their investments. Three Motley Fool contributors think they've found magnificent stocks retir...
2024-06-30 10:35:45 ET Summary If you want a massive dividend snowball: Get the right combination of dividend yield and growth for maximum compounding effect. Dividend Aristocrats may not always be the best choice due to high valuations and low yields. I refine a list of Divid...
2024-06-29 15:44:55 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End ...
News, Short Squeeze, Breakout and More Instantly...
AbbVie to Host Second-Quarter 2024 Earnings Conference Call PR Newswire NORTH CHICAGO, Ill. , July 2, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its second-quarter 2024 financial results on Thursday, July 25, 2024 , before the market opens. AbbVie wi...
2024-07-01 10:48:00 ET It's been a big year for most stocks, with the S&P 500 index up about 24% over the past 12 months. A rising market is wonderful for the stocks already in your portfolio, but finding new investment opportunities is a lot more challenging than it was a year ago....
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer PR Newswire As Previously Announced, Richard A. Gonzalez Retires as Chief Executive Officer to Become Executive Chairman Robert A. Michael Joins AbbVie Board of Directors NORTH CHICAGO, Ill....